Genfit (Genfit) FCF Yield % : -27.96 (As of May. 25, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Genfit FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Genfit's Trailing 12-Month Free Cash Flow is $-63.16 Mil, and Market Cap is $225.87 Mil. Therefore, Genfit's FCF Yield % for today is -27.96%.

The historical rank and industry rank for Genfit's FCF Yield % or its related term are showing as below:

GNFT' s FCF Yield % Range Over the Past 10 Years
Min: -90.83 Med: -6.88 Max: 58.02
Current: -27.96

During the past 13 years, the highest FCF Yield % of Genfit was 58.02%. The lowest was -90.83%. And the median was -6.88%.

GNFT's FCF Yield % is ranked worse than
65.36% of 1553 companies
in the Biotechnology industry
Industry Median: -14.53 vs GNFT: -27.96

Genfit's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Genfit FCF Yield % Historical Data

The historical data trend for Genfit's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genfit FCF Yield % Chart

Genfit Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-7.14

-63.54

45.08

-35.18

-32.92

Genfit Quarterly Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Genfit's FCF Yield %

For the Biotechnology subindustry, Genfit's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genfit's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genfit's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Genfit's FCF Yield % falls into.

Genfit FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Genfit's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-63.159	/	191.86475
	=	-32.92%

Genfit's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	4	/	191.86475
	=	0.00%

Genfit FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Genfit FCF Yield % Related Terms

Thank you for viewing the detailed overview of Genfit's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genfit (Genfit) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genfit SA (NAS:GNFT) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

GNFTF:USA 0QT6:UK GNFT:France XUPB:Germany

Address

Parc Eurasante, 885, Avenue Eugene Avinee, Loos, FRA, 59120

Website

https://www.genfit.com

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. The company conducts clinical trials in a variety of European and North American countries when advancing through stages of development. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.